BNET Industries
Last Fiscal Year Sales:$17.5M
- Private
- US
Dow Jones Description
Caraco Pharmaceutical Laboratories, Ltd. is one of the fastest growing companies in the generic pharmaceutical industry. Caraco is engaged in the business of developing, manufacturing, marketing and distributing generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, warehousing and non-warehousing chain drugstores and managed care providers, throughout the U.S. These products are intended to treat a variety of disorders including but not limited to the following: hypertension, arthritis, epilepsy, diabetes, antipsychotic, depression and pain management. Founded in 1984, Caraco is located in the Metro Detroit area and its facilities have a total foot print of approximately 180,000 sq ft. Caraco initially struggled as a start up company, however, its renaissance truly began after establishing an alliance with Sun Pharmaceutical Industries, Ltd. ("Sun"), currently the 5th largest pharmaceutical company in India. In 1997, Sun became Caraco's majority shareholder, and subsequently, the two companies entered into a technology transfer agreement. As disclosed, under the products agreement dated November 21, 2002, Sun agreed to transfer the technology for 25 products (all have been selected), which Caraco would file with the FDA. Also, Caraco has recently entered into a definitive agreement to market Sun ANDAs that are either approved or awaiting approval at the FDA. Between the technology transfer and marketing agreements, along with Caraco's...
Chief Executive Officer
Jitendra N DoshiNumber of Employees 174
Peer Companies
NAICS Code Medicinal and Botanical Manufacturing: 325411
News & Analysis
Filter by
caraco corp. - All News and Analysis
Zacks Analyst Blog Highlights: Schering-Plough Corp., Caraco Pharmaceutical Laboratories Ltd., Dr. Reddy's Laboratories Inc., GeoPharma Inc. and Mylan Pharmaceuticals Inc.
http://www.profit.zacks.com/ CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news...
Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Imitrex® Tablets
DETROIT, Aug. 11 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) has launched sumatriptan succinate tablets on behalf of Sun Pharmaceutical Industries Ltd. Sun Pharma, immediately following Sun Pharma's recently received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application...
Law Offices of Howard G. Smith, Representing Investors of Caraco Pharmaceutical Laboratories, Ltd., Announces Class Action Lawsuit
BENSALEM, Pa. -- Law Offices of Howard G. Smith, representing investors of Caraco Pharmaceutical Laboratories, Ltd. (â??Caracoâ?? or the â??Companyâ??)(AMEX:CPD), has filed a class action lawsuit in the United...
Shalov Stone Bonner & Rocco LLP Announces Investor Class Action Against Caraco Pharmaceutical Laboratories, Ltd.
Shalov Stone Bonner & Rocco LLP announces that a class action lawsuit has been filed on behalf of purchasers of the securities of Caraco Pharmaceutical Laboratories, Ltd. ("Caraco" or the "Company") (AMEX: CPD) between May 29, 2008 and June 25, 2009, inclusive (the "Class Period"). The lawsuit...
Caraco Pharmaceutical Laboratories, Ltd. Announces Settlement of Ethyol® ANDA Patent Litigation
DETROIT, Aug. 3 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announces today that it has executed a settlement agreement with MedImmune, stipulating the dismissal of the lawsuits filed in the United States District Court for the District of Maryland regarding the submission of an Abbreviated...
Kendall Law Group Announces Class Action Against Caraco Pharmaceutical Laboratories
Kendall Law Group has filed a lawsuit against Caraco Pharmaceutical Laboratories (AMEX: CPD) on behalf of investors who purchased CPD stock that was artificially inflated between May 29, 2008 and June 25, 2009. Any shareholder, who purchased CPD stock during the above time period, may move the...
Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2010
DETROIT, July 28 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) recorded net sales of $48.1 million in the first quarter of Fiscal 2010, ended June 30, 2009, compared to $108.3 million during the corresponding period of Fiscal 2009. The reduction in sales was primarily due...
Caraco Pharmaceutical Laboratories, Ltd. Announces Change to Executive Team as Jitendra N. Doshi Assumes Position of CEO
DETROIT, July 28 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that Jitendra N. Doshi has been appointed as interim Chief Executive Officer and as a Director of the Company following the resignation of Daniel H. Movens as Chief Executive Officer and as a Director...
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Caraco Pharmaceutical Laboratories, Ltd. (NYSE: CPD)
On July 17, 2009, a class action lawsuit was filed in the United States District Court for the Eastern District of Michigan against Caraco Pharmaceutical Laboratories, Ltd. (NYSE: CPD). The complaint alleges violations of federal securities laws, Sections 10b and 20a of the Securities Exchange Act of...
Caraco Pharmaceutical Laboratories, Ltd. Announces Filing of Purported Class Action Lawsuits
DETROIT, July 23 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that on July 17, 2009 and July 23, 2009, two purported federal securities class action lawsuits were filed in the United States District Court for the Eastern District of Michigan against the Company and...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Jitendra N Doshi | Chief Executive Officer |
| Mukul Rathi | Interim Chief Financial Officer |
| Gurpartap Singh Sachdeva | Senior Vice President Business Strategies |
| Robert Kurkiewicz | Senior Vice President, Technical |
| Singh Sachdeva Gurpartap | Senior Vice President, Business Strategies |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Dilip S Shanghvi | Chairman of the Board of Directors |
| Timothy S Manney | Chairman |
| Daniel H Movens | Board of Directors |
| John D Crissman | Board of Directors |
| Madhava Reddy | Board of Directors |
| Sudhir V Valia | Board of Directors |
Mr. Doshi has been appointed as Caraco's interim Chief Executive Officer effective July 2009. From 2006 to July 2009, he served as the Executive Director of Sun Pharmaceutical Industries, Inc., a generic pharmaceutical company and wholly-owned subsidiary of Sun Pharma. Mr. Doshi has served Caraco in the following positions: Chief Financial Officer (November 2002 to January 2007), Chief Operating Officer (November 2002 to January 2007), interim Chief Executive Officer (September 2003 to May 2005) and Senior Vice President-Commercial (April 2001 to November 2002). From September 1999 to April 2001, Mr. Doshi was employed by Sun Pharma as General Manager Operations. From 1991 to 1999, Mr. Doshi was Managing Director of Aqua Bearing Ltd., an auto parts manufacturer organized under the laws of the Commonwealth of India.
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Chief Executive Officer | Current |
| Caraco Corporation | Board of Directors | Current |
| Caraco Corporation | Chief Financial Officer and Chief Operating Officer | Former |
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Interim Chief Financial Officer | Current |
| University of Calcutta | Former |
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Senior Vice President Business Strategies | Current |
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Senior Vice President, Technical | Current |
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Senior Vice President, Business Strategies | Current |
| Caraco Corporation | Board of Directors | Current |
Mr. Shanghvi has served as Chairman of the Board of Directors of Caraco since 1997. Mr. Shanghvi is the founder of Sun Pharma, its Managing Director since its inception in 1993, responsible for marketing, research and development and human resource development, and its Chairman since 1999. Also, since March 2007, Mr. Shanghvi is the Managing Director of Sun Pharma Advanced Research Company Ltd. Mr. Valia is Mr. Shanghvi's brother-in-law.
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Chairman of the Board of Directors | Current |
| Caraco Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Synova, Inc. | President | Current |
| Caraco Corporation | Chairman | Current |
| Synova, Inc. | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Board of Directors | Current |
| Caraco Corporation | Chief Executive Officer | Former |
| Anda, Inc | President | Former |
| Caraco Corporation | Chief | Former |
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Caraco Corporation | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
-
Arena Pharmaceuticals Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ARNA
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes

